Filter
123
Text search:
guidelines
for
pharmacovigilance
Featured
Recommendations
21
New Publications
33
Language
Document type
No document type
59
Guidelines
30
Studies & Reports
12
Manuals
11
Strategic & Response Plan
5
Fact sheets
2
Training Material
1
Situation Updates
1
Resource Platforms
1
Infographics
1
Countries / Regions
Kenya
8
South Africa
7
Western and Central Europe
6
India
5
Eastern Europe
5
Senegal
4
Uganda
4
Rwanda
4
Malawi
4
Nigeria
3
Ghana
3
Russia
3
Ethiopia
2
Nepal
2
Tanzania
2
Bangladesh
2
Sudan
2
Namibia
2
Latin America and the Carribbean
2
Global
2
Sierra Leone
1
Liberia
1
Morocco
1
Cameroon
1
Zimbabwe
1
Pakistan
1
Jordan
1
Afghanistan
1
Lebanon
1
Cambodia
1
Brazil
1
Botswana
1
Sri Lanka
1
South–East Asia Region
1
Western Pacific Region
1
Eastern Europe and Central Asia
1
Asia
1
Africa
1
Bhutan
1
Southern Africa
1
Maldives
1
Authors & Publishers
Publication Years
Category
Countries
54
Clinical Guidelines
24
Public Health
3
Pharmacy & Technologies
3
Women & Child Health
2
Capacity Building
1
Toolboxes
TB
23
Pharmacy
16
AMR
14
HIV
9
COVID-19
7
NTDs
6
Malaria
4
Rapid Response
1
Refugee
1
Caregiver
1
NCDs
1
Interim Guidance, 12 July 2021; This tool was developed to assess present and surge capacities for the treatment of COVID-19 in health facilities. It allows health facilities to assess the availability and status of stockout of critical COVID-19 med
...
Guidelines for the care and treatment of persons diagnosed with chronic hepatitis C virus infection
Interim guidance. 12 May 2021. The Continuity of essential health services: Facility Assessment Tool can be used by countries to rapidly assess the capacity of health facilities to maintain the provision of essential health services during the COVID-19 pandemic. It can help to alert the authorities
...
The Zimbabwe National Pharmacovigilance Policy Handbook, 2nd Edition updates the November 2013 version to indicate the Zimbabwe National Pharmacovigilance (PV) Centre’s compliance with the WHO
...
Communication to Healthcare Professionals Mar-2020
This guideline is intended to assist healthcare professionals in the participation of very important process of continuous surveillance of safety and efficacy of the health products which are used in their clinical practice. Continuous evaluation o
...
STATUTORY INSTRUMENTS | SUPPLEMENT No. 8 28th March, 2014 | STATUTORY INSTRUMENTS SUPPLEMENT | to The Uganda Gazette No. 18 Volume CVII dated 28th March, 2014 | Printed by UPPC, Entebbe, by Order of the Government. | STATUTORY INSTRUMENTS | 2014 No. 37.
Tuberculosis continues to represent a severe public health problem in the Region of the Americas, even more so in the case of indigenous peoples, whose TB incidence is much higher than that of the general population. To achieve tuberculosis control in these communities, it is necessary to respond t
...
Effective malaria case management requires quick access to diagnostics and antimalarial treatments to reduce illness and death. Artemisinin-based combination therapy (ACT) has been essential to malaria treatment since 2001, as it combines artemisinin for
...
Guidance for clinical case management of thrombosis syndrome with thrombocytopenia (TTS) following vaccination to prevent coronavirus disease (COVID-19)
Interim guidance 19 July 2021
his Framework begins with a desired future scenario and considers actions and interventions necessary to get there. It advocates for holistic view to address tuberculosis. The Framework revisits challenges and actions in four layers: TB specific; ch
...
Report: A survey conducted among the 27 high MDR-TB burden countries.
March – July 2015
Stop TB Partnership in collaboration with Medecins Sans Frontieres (MSF).
Accessed November 2017.
WHO and UNITAID
in collaboration with IMPAACT (International Maternal Pediatric Adolescent AIDS Clinical Trials) network, PENTA (Paediatric European Network for Treatment of AIDS) foundation and experts from the Paediatric Antiretroviral Working Gr
...
Guide for coordinators and data collectors - The WHO Operational Package for Assessing, Monitoring and Evaluating Country Pharmaceutical Situations is intended as a useful tool
...
